Cargando…

Increased Risk of Cerebrovascular Events in Patients with Cancer Treated with Bevacizumab: A Meta-Analysis

Arterial ischemia and hemorrhage are associated with bevacizumab, an inhibitor of vascular endothelial growth factor that is widely used to treat many types of cancers. As specific types of arterial ischemia and hemorrhage, cerebrovascular events such as central nervous system (CNS) ischemic events...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zuo, Pei-Yuan, Chen, Xing-Lin, Liu, Yu-Wei, Xiao, Chang-Liang, Liu, Cheng-Yun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2014
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4099178/ https://www.ncbi.nlm.nih.gov/pubmed/25025282 http://dx.doi.org/10.1371/journal.pone.0102484

Ejemplares similares

Angiogenesis Inhibitor Bevacizumab Increases the Risk of Ischemic Heart Disease Associated with Chemotherapy: A Meta-Analysis
por: Chen, Xing-Lin, et al.
Publicado: (2013)

Effect of ASA on the risk of cerebrovascular ischemic events in patients with PFO
por: Xu, Liang, et al.
Publicado: (2022)

Risk of Cerebrovascular Events in Pneumoconiosis Patients: A Population-based Study, 1996–2011
por: Chuang, Chieh-Sen, et al.
Publicado: (2016)

Inflammation of carotid plaques and risk of cerebrovascular events
por: Poredos, Pavel, et al.
Publicado: (2020)

A systematic review and meta-analysis on herpes zoster and the risk of cardiac and cerebrovascular events
por: Erskine, Nathaniel, et al.
Publicado: (2017)

Risk of Adverse Vascular Events in Newly Diagnosed Glioblastoma Multiforme Patients Treated with Bevacizumab: a Systematic Review and Meta-Analysis
por: Li, Xiaoqing, et al.
Publicado: (2015)

Factors Associated with Adverse Cardiovascular Events in Cancer Patients Treated with Bevacizumab
por: Ngo, Doan T. M., et al.
Publicado: (2020)

Bariatric Surgery and the Risk of Cerebrovascular Events: a Meta-analysis of 17 Studies Including 3,124,063 Subjects
por: Cai, Zixin, et al.
Publicado: (2022)

Increased risk of cerebrovascular accident related to non-alcoholic fatty liver disease: a meta-analysis
por: Hu, Jianping, et al.
Publicado: (2017)

Incidence and Risk Factors of Cerebrovascular Events Following Cardiac Catheterization
por: Korn‐Lubetzki, Isabelle, et al.
Publicado: (2013)

Increased heterogeneity of brain perfusion predicts the development of cerebrovascular accidents
por: Lin, Ting-Syuan, et al.
Publicado: (2021)

Elevated levels of adiponectin associated with major adverse cardiovascular and cerebrovascular events and mortality risk in ischemic stroke
por: Tu, Wen-Jun, et al.
Publicado: (2020)

Increased risk of hemorrhage in metastatic colorectal cancer patients treated with bevacizumab: An updated meta-analysis of 12 randomized controlled trials
por: Zhu, Xiaoqiang, et al.
Publicado: (2016)

Risk of Cardiovascular and Cerebrovascular Events in Polycystic Ovarian Syndrome Women: A Meta-Analysis of Cohort Studies
por: Zhang, Jun, et al.
Publicado: (2020)

Preventing Ischemic Cerebrovascular Events in High-Risk Patients With Non-disabling Ischemic Cerebrovascular Events Using Remote Ischemic Conditioning: A Single-Arm Study
por: Liu, Shimeng, et al.
Publicado: (2021)

Hepatic Events and Viral Kinetics in Hepatocellular Carcinoma Patients Treated with Atezolizumab plus Bevacizumab
por: Hsu, Chiun, et al.
Publicado: (2022)

Electrocardiographic abnormalities in acute cerebrovascular events
por: Wiwanitkit, Somsri, et al.
Publicado: (2013)

Flavivirus Infection Associated with Cerebrovascular Events
por: Estofolete, Cássia F., et al.
Publicado: (2020)

Preconditioning by Preceding Ischemic Cerebrovascular Events
por: Correia, Pamela N., et al.
Publicado: (2021)

Cardiovascular Adverse Events in Patients With Cancer Treated With Bevacizumab: A Meta‐Analysis of More Than 20 000 Patients
por: Totzeck, Matthias, et al.
Publicado: (2017)

Residual recurrence risk of ischaemic cerebrovascular events: concept, classification and implications
por: Wang, Yongjun
Publicado: (2021)

Long-term risk and predictors of cerebrovascular events following sepsis hospitalization: A systematic review and meta-analysis
por: Arero, Amanuel Godana, et al.
Publicado: (2022)

Bevacizumab significantly increases the risks of hypertension and proteinuria in cancer patients: A systematic review and comprehensive meta-analysis
por: Zhao, Tingting, et al.
Publicado: (2017)

Associations of Warfarin Use with Risks of Ischemic Cerebrovascular Events and Major Bleeding in Patients with Hyperthyroidism-Related Atrial Fibrillation
por: Liu, Sian-De, et al.
Publicado: (2022)

Elevated T/E(2) Ratio Is Associated with an Increased Risk of Cerebrovascular Disease in Elderly Men
por: Gong, Yanping, et al.
Publicado: (2013)

Elevation of Interleukin-18 Correlates With Cardiovascular, Cerebrovascular, and Peripheral Vascular Events: A Cohort Study of Hemodialysis Patients
por: Chang, Chih-Hsiang, et al.
Publicado: (2015)

Secondary prevention of major cerebrovascular events with seven different statins: a multi-treatment meta-analysis
por: Zhong, Ping, et al.
Publicado: (2017)

Leukocyte subtypes and adverse clinical outcomes in patients with acute ischemic cerebrovascular events
por: Wang, Anxin, et al.
Publicado: (2021)

Increased risk of adverse drug events secondary to bevacizumab treatment in patients with advanced or metastatic breast cancer: a meta-analysis of randomized controlled trials
por: Shin, Sooyoung, et al.
Publicado: (2018)

Bevacizumab and risk of intracranial hemorrhage in patients with brain metastases: a meta-analysis
por: Yang, Lin, et al.
Publicado: (2017)

Elevated non-HDL-C/HDL-C ratio increases the 1-year risk of recurrent stroke in older patients with non-disabling ischemic cerebrovascular events: results from the Xi’an Stroke Registry Study of China
por: Liu, Zhongzhong, et al.
Publicado: (2023)

Bevacizumab increases the risk of anastomosis site leakage in metastatic colorectal cancer
por: Kim, Seijong, et al.
Publicado: (2022)

Rationale and Study Design for a Single-Arm Phase IIa Study Investigating Feasibility of Preventing Ischemic Cerebrovascular Events in High-Risk Patients with Acute Non-disabling Ischemic Cerebrovascular Events Using Remote Ischemic Conditioning
por: Liu, Shi-Meng, et al.
Publicado: (2018)

Clinical observation of the efficacy of Bevacizumab combined with argon green laser in treating fundus macular edema
por: Shao, Yi, et al.
Publicado: (2017)

Cervicomedullary hemangioblastoma treated with bevacizumab
por: Mak, Gloria, et al.
Publicado: (2020)

Risk of Ischemic Cerebrovascular and Coronary Events in Adult Users of Anticonvulsant Medications in Routine Care Settings
por: Patorno, Elisabetta, et al.
Publicado: (2013)

Assessing risk factors for major adverse cardiovascular and cerebrovascular events during the perioperative period of carotid angioplasty with stenting patients
por: Liu, Juan, et al.
Publicado: (2016)

Incidence and Risk of Hypertension in Cancer Patients Treated With Atezolizumab and Bevacizumab: A Systematic Review and Meta-Analysis
por: Jiang, Linhan, et al.
Publicado: (2021)

Bevacizumab Dose Affects the Severity of Adverse Events in Gynecologic Malignancies
por: Lee, Shu-Ping, et al.
Publicado: (2019)

Infarction Patterns and Recurrent Adverse Cerebrovascular Events in Moyamoya Disease
por: Yu, Shao-Chen, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_5nve18ul0sbe2bf0p1pqkjl9gh